Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 7432.33 | 459 / 459 | 100% | 45.94 | 1118 / 1118 |
esophagus | 100% | 9752.04 | 1445 / 1445 | 100% | 44.17 | 183 / 183 |
intestine | 100% | 8236.47 | 966 / 966 | 100% | 41.13 | 527 / 527 |
lung | 100% | 6638.75 | 578 / 578 | 100% | 39.77 | 1155 / 1155 |
ovary | 100% | 4686.97 | 180 / 180 | 100% | 39.10 | 430 / 430 |
prostate | 100% | 6787.24 | 245 / 245 | 100% | 42.53 | 502 / 502 |
stomach | 100% | 5625.76 | 359 / 359 | 100% | 40.12 | 286 / 286 |
brain | 100% | 5643.07 | 2636 / 2642 | 100% | 31.85 | 705 / 705 |
bladder | 100% | 8025.10 | 21 / 21 | 100% | 35.04 | 502 / 504 |
uterus | 100% | 7416.49 | 170 / 170 | 100% | 35.01 | 457 / 459 |
thymus | 100% | 6274.31 | 653 / 653 | 100% | 40.38 | 602 / 605 |
pancreas | 99% | 3914.37 | 326 / 328 | 99% | 37.69 | 177 / 178 |
skin | 100% | 6648.99 | 1805 / 1809 | 99% | 27.23 | 465 / 472 |
kidney | 100% | 5593.33 | 89 / 89 | 98% | 30.76 | 885 / 901 |
adrenal gland | 100% | 5571.31 | 258 / 258 | 96% | 31.08 | 221 / 230 |
liver | 43% | 679.02 | 98 / 226 | 65% | 9.98 | 264 / 406 |
adipose | 100% | 7798.65 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9134.97 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 6128.93 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3974.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 32.57 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.70 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 30.66 | 79 / 80 |
heart | 99% | 5677.61 | 849 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 9.97 | 26 / 29 |
peripheral blood | 87% | 2983.73 | 810 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001778 | Biological process | plasma membrane repair |
GO_2000641 | Biological process | regulation of early endosome to late endosome transport |
GO_0051036 | Biological process | regulation of endosome size |
GO_0051469 | Biological process | vesicle fusion with vacuole |
GO_0039702 | Biological process | viral budding via host ESCRT complex |
GO_0036258 | Biological process | multivesicular body assembly |
GO_0061763 | Biological process | multivesicular body-lysosome fusion |
GO_1901673 | Biological process | regulation of mitotic spindle assembly |
GO_0045324 | Biological process | late endosome to vacuole transport |
GO_0016236 | Biological process | macroautophagy |
GO_1903541 | Biological process | regulation of exosomal secretion |
GO_0043162 | Biological process | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
GO_0061952 | Biological process | midbody abscission |
GO_0090148 | Biological process | membrane fission |
GO_0006997 | Biological process | nucleus organization |
GO_0051258 | Biological process | protein polymerization |
GO_0010824 | Biological process | regulation of centrosome duplication |
GO_0046761 | Biological process | viral budding from plasma membrane |
GO_1902774 | Biological process | late endosome to lysosome transport |
GO_0032509 | Biological process | endosome transport via multivesicular body sorting pathway |
GO_0071985 | Biological process | multivesicular body sorting pathway |
GO_0019076 | Biological process | viral release from host cell |
GO_0006915 | Biological process | apoptotic process |
GO_0015031 | Biological process | protein transport |
GO_0006914 | Biological process | autophagy |
GO_0044790 | Biological process | suppression of viral release by host |
GO_0097352 | Biological process | autophagosome maturation |
GO_0007080 | Biological process | mitotic metaphase chromosome alignment |
GO_0031468 | Biological process | nuclear membrane reassembly |
GO_0032467 | Biological process | positive regulation of cytokinesis |
GO_0000815 | Cellular component | ESCRT III complex |
GO_0030496 | Cellular component | midbody |
GO_0005643 | Cellular component | nuclear pore |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005769 | Cellular component | early endosome |
GO_0000776 | Cellular component | kinetochore |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005828 | Cellular component | kinetochore microtubule |
GO_0005829 | Cellular component | cytosol |
GO_0005770 | Cellular component | late endosome |
GO_0005771 | Cellular component | multivesicular body |
GO_1904930 | Cellular component | amphisome membrane |
GO_0032585 | Cellular component | multivesicular body membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0031210 | Molecular function | phosphatidylcholine binding |
GO_0005515 | Molecular function | protein binding |
GO_1990381 | Molecular function | ubiquitin-specific protease binding |
GO_0140678 | Molecular function | molecular function inhibitor activity |
Gene name | CHMP3 |
Protein name | Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Neuroendocrine differentiation factor) (Vacuolar protein sorting-associated protein 24) (hVps24) |
Synonyms | NEDF CGI149 CGI-149 VPS24 |
Description | FUNCTION: Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. Selectively binds to phosphatidylinositol 3,5-bisphosphate PtdIns(3,5)P2 and PtdIns(3,4)P2 in preference to other phosphoinositides tested. Involved in late stages of cytokinesis. Plays a role in endosomal sorting/trafficking of EGF receptor. Isoform 2 prevents stress-mediated cell death and accumulation of reactive oxygen species when expressed in yeast cells. . |
Accessions | ENST00000409727.5 [Q9Y3E7-4] ENST00000263856.9 [Q9Y3E7-1] Q9Y3E7 ENST00000409225.2 [Q9Y3E7-2] |